Skip to content
Search

Latest Stories

PHE's analysis of Covid-19 data 'disappoints' pharmacy organisations

People from black, Asian or minority ethnic (BAME) backgrounds in England are twice as likely to die after becoming infected with COVID-19, an official study said on Tuesday (June 2), putting pressure on the government to outline plans to protect the most at-risk communities.

While the review by Public Health England (PHE) reinforced previous studies which indicated ethnic minority groups were more at risk from the virus, it was not accompanied by specific government advice for those people.


The report has been criticised for failing to make recommendations which were a key part of its original remit. National pharmacy organisations have expressed their disappointment at the lack of any “new insight” in the PHE review.

“The outcome of this review is disappointing as it re-states the problem, rather than offering new insight,” President of Royal Pharmaceutical Society Sandra Gidley said.

The Pharmacists’ Defence Association complained that the report failed “to discuss the potential reasons why BAME individuals are at a higher risk in any depth.”

“The disparity in risk was first officially confirmed by a report from the Office for National Statistics (ONS) which was published on 7th May… this report, coming nearly a month after the ONS report release in May, provides no meaningful guidance on what steps employers and those at risk should be taking to mitigate that risk,” it added.

Gidley further noted: “The Government needs to act much more quickly on this issue to make sure BAME pharmacists feel as safe as possible. This involves engaging with pharmacy on the topic to bring about real change to support and protect our workforce. There are also opportunities here about how pharmacists can support vulnerable populations and tackle health inequalities.

“The first step on from this report must be to ensure robust risk assessment and protection is in place for BAME staff along with other vulnerable groups, such as staff with existing health conditions.

Speaking at the daily coronavirus press briefing on June 2, Health Secretary Matt Hancock said that equalities minister Kemi Badenoch would look at the issue further.

“We will put action in place as soon as we can. We won’t wait for a report,” Hancock said.

The PHE report said that people of Bangladeshi ethnicity had approximately twice the risk of death of people who were white British.

UK’s testing chief John Newton said although Tuesday’s report showed worse outcomes for minority groups, it may not be directly caused by their ethnicity, but related to their job.

“It is quite a long report and there is a great deal of background and detailed information we think will be helpful. What we would like to do is get a lot of discussion about all these with the various groups involved in responding to it.

“It is not easy to go directly from the analysis to making recommendations and we need to get the report widely disseminated and discussed before deciding what needs to be done, but clearly there are some fairly obvious conclusions that can be drawn, even from the data we have.”

(With input from Reuters)

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less